Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimatesMaría Sepúlveda, Albert Saiz, Sara Llufriú et al.|Multiple Sclerosis Journal|2017Cited by 100
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MSCristina Ramo‐Tello, Laia Grau‐López, Xavier Montalbán et al.|Multiple Sclerosis Journal|2013Cited by 75